Company Filing History:
Years Active: 2015
Title: Winfried Heyse: Innovator in Pharmaceutical Cocrystals
Introduction
Winfried Heyse is a notable inventor based in Mörfelden-Walldorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel solid forms of agomelatine. His work has implications for pharmaceutical development and drug formulation.
Latest Patents
Heyse holds a patent for "Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation." This invention relates to the creation of new solid forms of agomelatine, specifically focusing on pharmaceutically acceptable cocrystals. The patent outlines methods for preparing these cocrystals, which exhibit physico-chemical properties suitable for pharmaceutical applications. He has 1 patent to his name.
Career Highlights
Winfried Heyse is associated with Zentiva K.S., where he continues to contribute to pharmaceutical innovations. His expertise in cocrystal technology has positioned him as a valuable asset in the industry.
Collaborations
Heyse has collaborated with notable colleagues, including Gary James Miller and Ludek Ridvan. These partnerships have enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Winfried Heyse's work in pharmaceutical cocrystals represents a significant advancement in drug formulation. His innovative approach and collaboration with industry professionals continue to influence the field positively.